Indianapolis-based FAST Diagnostics gets funding from BioCrossroads’ seed fund
Money will help the company refine its tool to treat acute kidney injury.
Health Care & Life Sciences
Articles
Gregory & Appel celebrates anniversary by writing 125 checks to charity
The awards of $500 each total $62,500. “In lieu of doing a party, it was more
appropriate and more the corporate culture of Gregory & Appel to do something charitable,”
Vice President Steve Appel said.
Cook Group Inc. owner says health reform’s tax on medical devices could kill jobs
Bloomington-based Cook Group Inc. might have to cut as many as 1,000 local jobs if Congress enacts a tax on medical devices
to pay for health care reform, company founder Bill Cook said in an interview.
Lilly needs to sell more Effient before Zyprexa loses patent protection
Sales of Eli Lilly and Co.’s newest drug were an afterthought during its Oct. 21 report on third-quarter earnings. The blood thinner Effient totaled up $22.6 million in sales—a mere 0.4 percent of Lilly’s total for
the quarter.
Eli Lilly CEO banking on new drug pipeline
CEO John Lechleiter says Lilly’s pipeline has helped it rebound from significant patent losses three times during his 30-year
career at the company. He’s betting there will be a fourth.
Zimmer profits fall, but beat expectations
The Warsaw-based company recorded a third-quarter profit of $150 million, down 30 percent from the same quarter a year ago.
Goodwill executive to lead national health care board
Goodwill Industries executive Keith Reissaus has been tapped to run Washington, D.C.-based Leapfrog Group, an industry coalition.
Reissaus gained control of health care costs by giving employees incentives to care about their health.
Indiana insurance industry weathers hard times
Employment in Indiana’s insurance industry has remained stable despite a poor economy.
Lilly, GE announce cancer diagnostic breakthrough
Eli Lilly and Co. and General Electric Co. say they’ve made a breakthrough in cancer research that could help Lilly cut the size and cost of its clinical trials.
Uncertainty over drug pipeline sends Lilly shares down
For the first time publicly, Eli Lilly and Co. officials admitted the obvious: Their pipeline products
aren’t likely to offset the revenue the company will lose after its two bestsellers, Zyprexa and Cymbalta, lose patent exclusivity.
Democrats eye insurance industry’s antitrust protection
Top Senate Democrats intend to try to strip the health insurance industry of its exemption from federal antitrust laws, according
to congressional officials, the latest evidence of a deepening struggle over President Barack Obama’s effort to overhaul the
health care industry.
Bristol-Myers Squibb plans 113 job cuts in southern Indiana
Drugmaker Bristol-Myers Squibb Co. plans to close one of its southern Indiana facilities and cut jobs at another.
Lilly reports $942 million profit in third quarter
Excluding special items, Eli Lilly and Co.’s earnings per share spike 22 percent on the strength of Alimta, Cymbalta and Humalog
sales. Lilly’s revenue rose 7 percent in the quarter over the same period of 2008,
to $5.56 billion.
Cook: Tax could kill 1,000 jobs in Bloomington
Bloomington-based Cook Group Inc. could find itself cutting as many as 1,000 local jobs if Congress enacts a tax on
medical devices to pay for health care reform, company founder Bill Cook said in an interview.
Medco plans to compare Plavix, Effient in study
Medco Health Solutions Inc. said Tuesday it will compare the blood thinner Plavix, the world’s second-best selling drug, with
Effient, a potential blockbuster drug sold by Indianapolis-based Eli Lilly and Co.
Cook calls for new approach to health reform
Founder of medical device firm says Congress should fund network of low-cost clinics.
Afraid to die
Fear of death may be causing Americans to expect too much from our medical system when it comes to prolonging the lives of
the old and infirm.
Manchester wants doctoral pharmacology program
Manchester College officials say they want to start a pharmacy school in Fort Wayne starting in the fall of 2012.
Endocyte receives $26M infusion from investors
West Lafayette-based Endocyte Inc. announced Friday that it has closed on $26 million in equity financing to help the company
continue developing cancer-fighting drugs.
State’s health IT groups seek stimulus funds
Some of Indiana’s leading organizations in health information technology are collaborating on an effort to receive several
million dollars of stimulus funding.